The number of inspections at manufacturing facilities abroad might increase by 50% this year as the FDA opens more offices and assigns more people in other countries, especially in China, Mexico and India, said Benjamin England, founder of consultancy firm FDAImports.com. FDA staff abroad "won't be doing the inspections, but they will be able to facilitate arrangements between the agency and foreign governments to speed things up," England said.

Related Summaries